Australasian Dentist Magazine Nov Dec 2021

Category 6 AustrAlAsiAn Dentist t he respiratory Dental institute was created by experienced specialist clinicians involved in the treatment of patients with sleep Apnoea and snoring. the team is made up of: u A/Professor Michael stubbs- Oral Medicine specialist u Dr linda schachter- respiratory and sleep Physician u Mr Peter Field- Dental sleep Medicine Business Advisor Obstructive sleep apnoea is suspected to occur in at least 10% of the population, however at this time only 1% of this population group are diagnosed and treated. in the past 25 years, the science of sleep apnoea and its effects on a patient’s health is now well known. it is a significant risk factor for multiple health conditions including myocardial infarct, cardiac arrhythmia or stroke as well as affecting quality of life of our patients through daytime fatigue and is a significant risk factor in transport road accidents. the role of the dentist is an important one in both recognizing patients who have symptoms, signs or risk factors for sleep apnoea, and treating these patients. Once identified, dentists have a unique opportunity to be involved in the making of custom-made devices to assist in keeping patients’ upper airway open at night. the questions we often hear from colleagues are, “How do we find out more about treating our patients with snoring or sleep apnoea?” But more importantly, colleagues would often say they had “undertaken a course and then return to their practices with some knowledge but were uncertain how to integrate this into their actual day to day practices.” this was the motivation behind the creation of the respiratory Dental institute. the respiratory Dental institute was created to both educate and offer professional ongoing support to our interested dental colleagues via online courses, online regular webinars and mentorship member programs. it’s in these member programs in which colleagues can submit cases and discuss with us direct guidance on what is the best treatment approach. like we did when we completed dental school, the encouragement and direct support over time enables you to successfully treat your own patients with the knowledge that you have access to specialist colleagues in the field of Dental sleep Medicine if you need more assistance. this assistance is further enhanced by our colleague, Mr Peter Field, who is well known in the dental profession, and can now help by training your staff (reception/ practice manager) on how to create a dental sleep medicine business. the respiratory Dental institute was not created to promote one brand of device, but to provide the knowledge so you can choose whatever device(s) you wish to use. We also provide all dentists enrolling in the training programs the tools you need to practice. We are experts in the field of dental sleep medicine and have educated dental colleagues for many years in this space. u If you would like to find out more, take a look at our webpage at: www.respiratorydentalinstitute.com.au, or email us on admin@ respiratorydentalinstitute.com.au the respiratory Dental institute Highlighting the role of the dentist in both recognizing patients who have symptoms and treating these patients n wS By A/Professor Michael Stubbs G eistlich Pharma AG, a swiss manufacturer of biomaterials, has acquired the italian bone scraper manufacturer Meta technologies s.r.l. with immediate effect. the two companies were quick to point out that this acquisition brings together what has been an excellent match for many years. Meta’s bone scrapers (safescraper ® , safescraper ® twist and Micross ® ) and Geistlich’s biomaterials, (Geistlich Bio- Oss ® , Geistlich Bio-Gide ® , Geistlich Mucograft ® , and now also Geistlich Fibro- Gide ® , the latest innovation in soft-tissue regeneration) are typically used in oral regeneration and often used together, particularly when harvesting autologous bone andmixing it withGeistlich Bio-Oss ® granules, for long-term predictable bone volume augmentation. “today marks a significant milestone for Geistlich Pharma,” said Geistlich Pharma Australia’s managing director, Dr torben Hackl. “As this is our first, but probably not last, takeover in the company’s 170-year history. Both companies are known worldwide for their highly regarded, gold standard product portfolios, but the synergies extend beyond our products to the people and the family- oriented culture being the driving force behind both companies. We look forward to welcoming the entire Meta team to our extended Geistlich family.” With this acquisition, Geistlich Pharma has become the exclusive supplier of Meta bone scrapers world- wide, and Geistlich Pharma Australia and new Zealand, known for providing clinicians with predictable, evidence- based regenerative products researched, developed and manufactured under one roof, is now also the go-to brand providing quality, high-end bone scrapers made by the world’s leading manufacturer. u For any further information contact our customer service team on 1800 776 326 or your local Geistlich Specialist in Australia and New Zealand. geistlich Pharma announces global takeover of Meta technologies